Linc AB
STO:LINC

Watchlist Manager
Linc AB Logo
Linc AB
STO:LINC
Watchlist
Price: 73.6 SEK 1.8% Market Closed
Market Cap: kr4.3B

P/E

-10.7
Current
427%
Cheaper
vs 3-y average of 3.3

Price to Earnings (P/E) ratio shows how much investors pay for each dollar of a company`s earnings. It`s calculated by dividing the company`s market value by its total earnings.

P/E
-10.7
=
Market Cap
kr4.3B
/
Net Income
kr-399.6m

Price to Earnings (P/E) ratio shows how much investors pay for each dollar of a company`s earnings. It`s calculated by dividing the company`s market value by its total earnings.

P/E
-10.7
=
Market Cap
kr4.3B
/
Net Income
kr-399.6m

Valuation Scenarios

Linc AB is trading above its 3-year average

If P/E returns to its 3-Year Average (3.3), the stock would be worth kr-22.51 (131% downside from current price).

Statistics
Positive Scenarios
0/4
Maximum Downside
-324%
Maximum Upside
No Upside Scenarios
Average Downside
206%
Scenario P/E Value Implied Price Upside/Downside
Current Multiple -10.7 kr73.6
0%
3-Year Average 3.3 kr-22.51
-131%
5-Year Average 2.8 kr-19.28
-126%
Industry Average 15.2 kr-104.9
-243%
Country Average 23.9 kr-164.94
-324%

Forward P/E
Today’s price vs future net income

Not enough data available to calculate forward P/E

Market Distribution

Lower than 100% of companies in Sweden
Percentile
0th
Based on 1 178 companies
0th percentile
-10.7
Low
0 — 17.4
Typical Range
17.4 — 32.1
High
32.1 —
Distribution Statistics
Sweden
Min 0
30th Percentile 17.4
Median 23.9
70th Percentile 32.1
Max 8 163.4

Linc AB
Glance View

Market Cap
4.3B SEK
Industry
Financial Services

Linc AB is an investment company that focuses on long-term share ownership in the Nordic life science market. The company is headquartered in Stockholm, Stockholm. The company went IPO on 2021-05-28. Linc invests in product-oriented companies within the Nordic Life Science industry - primarily in pharmaceutical and medical technology companies. The investments are made in both private and public companies and in research and operational companies. Typically, investments in drug development take place in an earlier phase compared to investments in medical technology. Linc Invest is an active and long-term owner with a wide industrial network to support the portfolio companies. The firm works together with the management, founders and board to realize the inherent potential that exists in the investment, have ambitious plans for further development and expansion and actively participate in the nomination committee work.

LINC Intrinsic Value
Not Available
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett